Guoqiang C. Wang
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications
Perceptions and attitudes towards obesity and metabolic and bariatric surgery for weight loss in children and adolescents: a survey among a subset of Chinese residents.
Journal: BMC public health
Published: February 28, 2026
Liquid biopsy-based multi-omics approach for early detection of hepatocellular carcinoma (ASCEND-Hep): a multiphase prospective development and validation study.
Journal: BMC medicine
Published: January 07, 2026
Mutant KRAS Suppresses DNA Sensing by Remodeling Membrane Tension to Clear Extracellular Tumor DNA.
Journal: Cancer research
Published: October 28, 2025
Prospective evaluation of radical surgery for adenocarcinoma of oesophagogastric junction: real-world insights from the CLAEG study.
Journal: Gut
Published: October 27, 2025
Long non-coding RNA ZBTB46-AS1 promotes ovarian cancer progression through regulation of p53 activity by TAF6 protein.
Journal: American journal of translational research
Published: October 09, 2025
ITHindex: An integrated web-based platform for intratumor heterogeneity evaluation.
Journal: PLOS digital health
Published: September 22, 2025
Development of a chaperone-mediated protein degrader targeting ERK5 that efficaciously reduces tumor growth.
Journal: Cell communication and signaling : CCS
Published: September 04, 2025
Efficacy and safety comparisons of PD-1 versus PD-L1 inhibitors in patients with solid cancer: a systematic review and meta-analysis.
Journal: Journal of the National Cancer Center
Published: August 21, 2025
CDKN1A and cellular senescence are associated with immune resistance in advanced lung adenocarcinoma.
Journal: Clinical and experimental medicine
Published: August 06, 2025
Prophylactic hyperthermic intraperitoneal chemotherapy is associated with improved disease-free survival in pathologic T4 colorectal cancer: a propensity score-matched cohort study.
Journal: World journal of surgical oncology
Published: August 04, 2025
Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRASG12D Inhibitor.
Journal: Cancer discovery
Published: August 02, 2025
NF1/2 mutations predict favorable benefit from immune checkpoint inhibitor-based therapies over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma.
Journal: Clinical and experimental medicine
Published: July 22, 2025
Last Updated: 09/26/2026